This episode explores a pivotal EU court ruling on distributor obligations under the Medical Devices Regulation, clarifying due care requirements and reinforcing manufacturers’ primary responsibility for product classification in the medical device supply chain.

This episode breaks down the FDA’s new Rare Disease Framework Initiative—launched in October 2026—which aims to consistently apply regulatory flexibility for rare disease therapies by establishing a centralized innovation hub, engaging outside experts, and implementing risk-based approaches to evidence and manufacturing standards.

This episode discusses the Manhattan District Attorney’s new Corporate Crime and Antitrust Task Force, highlighting expanded state-level enforcement risks—including AI-facilitated offenses—for organizations and their leaders, with a focus on "systemic accountability" and heightened scrutiny of key sectors and counterparties.

This episode provides a concise overview of the SEC’s October 9, 2026 proposed Rule 17A-7 under the 1940 Act, highlighting expanded eligibility for cross-trades, updated pricing methods, new compliance and oversight responsibilities, and the operational and reporting impacts for fund advisors and compliance officers.

This episode covers the SEC’s September 2026 no-action letter to the Mutual Fund Directors Forum, explaining the approval of a “Directed Voting Program” for mutual funds, how it incorporates retail voting frameworks and governance safeguards under the 1940 Act, and what it means for fund shareholders amid rising proxy campaign costs.

To read the alert that this AI-generated podcast is based on, please visit: https://www.ropesgray.com/en/insights/alerts/2026/09/sec-staff-greenlights-directed-voting-programs-for-funds

This episode breaks down the Ninth Circuit’s September 2026 decision in Dovi v. GitHub, Inc., exploring how the DMCA applies to generative AI coding tools and what the ruling means for developers, enterprises, and investors.

This episode explores the Department of Justice's new National Fraud Enforcement Division, highlighting its data-driven approach to targeting fraud against taxpayer dollars and advising companies in high-risk industries to proactively strengthen compliance and data analytics.

This episode examines recent Delaware and New York court decisions dismissing Securities Act claims against mutual funds, clarifying that industry-standard, GAAP-compliant accounting practices do not constitute material misstatements or omissions under federal securities law.